Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps reduce transplant-related complications in patients undergoing hematopoietic cell transplant (HCT). Ongoing review of recommendations and guidance enables clinicians to improve evaluation, treatment strategies, and management, which ultimately benefits overall patient outcomes.
Today's rundown features a curated selection of guidelines and consensus statements on and related to HCT that were published within the last five years from North American and international sources.
HCT Guidelines and Consensus Statements
- Transplantation in Classical Hodgkin Lymphoma
- American Society for Transplantation and Cellular Therapy (ASTCT), December 2025
- Haematopoietic Cell Transplantation (HCT) and CAR-T Haematological Diseases, Solid Tumours and Immune Disorders
- European Society for Blood and Marrow Transplantation (EBMT), September 2025
- Allogeneic Hematopoietic Cell Donor Selection
- National Marrow Donor Program (NMDP), July 2025
- Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients
- American Society for Transplantation and Cellular Therapy (ASTCT), June 2025
- Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy
- American Society for Transplantation and Cellular Therapy (ASTCT), June 2025
- Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
- American Society for Transplantation and Cellular Therapy (ASTCT), June 2025
- Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia
- American Society for Transplantation and Cellular Therapy (ASTCT), June 2025
- Management of Human Herpesvirus B6 After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy
- American Society for Transplantation and Cellular Therapy (ASTCT), May 2025
- Allogenic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome
- American Society for Transplantation and Cellular Therapy (ASTCT) / United States Cutaneous Lymphoma Consortium (USCLC), April 2025
- Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients
- American Society for Transplantation and Cellular Therapy (ASTCT), February 2025
- Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia
- American Society for Transplantation and Cellular Therapy (ASTCT), September 2024
- Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies
- American Society for Transplantation and Cellular Therapy (ASTCT), September 2024
- Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies
- American Society for Transplantation and Cellular Therapy (ASTCT), July 2024
- Risk of Secondary Oral Cancer Following Hematopoietic Cell Transplantation
- Multinational Association of Supportive Care in Cancer (MASCC) / International Society of Oral Oncology (ISOO), July 2024
- Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma
- American Society for Transplantation and Cellular Therapy (ASTCT), July 2024
- Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation
- American Society for Transplantation and Cellular Therapy (ASTCT), April 2024
- Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy
- Consensus and Physician Experts (CPE), February 2024
- Management of Fever and Neutropenia in Pediatric Patients with Cancer and Hematopoietic Cell Transplantation Recipients
- Consensus and Physician Experts (CPE), January 2023
- Transplant Referral Timing Guidelines
- American Society for Transplantation and Cellular Therapy (ASTCT), March 2022
Check out other clinical guidelines and sign up for alerts to stay informed on the latest published guidelines and insights.
Copyright © 2026 Guideline Central, all rights reserved.